COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Case-fatality rates and risk of death from COVID-19 and influenza A/H3N2 in Braz...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Scientific letter
Case-fatality rates and risk of death from COVID-19 and influenza A/H3N2 in Brazil: A nationwide ecological study
Tasas de letalidad y riesgo de muerte por COVID-19 e influenza A/H3N2 en Brasil: un estudio ecológico a nivel nacional
Paulo Ricardo Martins-Filhoa,
Corresponding author
prmartinsfh@gmail.com

Corresponding author.
, Jerocílio Maciel de Oliveira Júniora, Cliomar Alves dos Santosb
a Health Sciences Graduate Program, Investigative Pathology Laboratory, Aracaju, Sergipe, Brazil
b Government of Sergipe State, Health Foundation Parreiras Horta, Central Laboratory of Public Health (LACEN/SE), Aracaju, Sergipe, Brazil
Read
398
Times
was read the article
68
Total PDF
330
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2022.05.015
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 10 1 11
2024 April 39 23 62
2024 March 50 6 56
2024 February 63 8 71
2024 January 30 3 33
2023 December 16 3 19
2023 November 31 1 32
2023 October 44 3 47
2023 September 9 3 12
2023 June 1 2 3
2023 April 3 3 6
2023 March 34 12 46

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Infección bacteriana/fúngica en pacientes con...
Enferm Infecc Microbiol Clin. 2022;40:158-65
Eosinofilia y dolor abdominal tras una neumonía grave...
Enferm Infecc Microbiol Clin. 2021;39:478-80
Síndrome febril al regreso del trópico durante la...
Enferm Infecc Microbiol Clin. 2021;39:477-8


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos